More evidence for the benefits of aggressive lipid-lowering with statins has come from the IDEAL study, which randomised nearly 9000 post-MI patients to either 80 mg of atorvastatin or 20/40 mg simvastatin daily. Terje Pedersen from Ulleval University Hospital in Norway presented the findings.
[audio:https://www.audiomedica.com/podcasting/aha2005/Terje_Pedersen.mp3]
Hypertension: Pressure Different at the Centre 16 Nov, 2005 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 15 Nov, 2006 Stroke Prevention: Aspirin is Different in Women 17 Nov, 2005 Drug-Coated Balloon for In-Stent Restenosis: First Experience 12 Sep, 2005 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014